Gleevec

Type: Product
Name: Gleevec
First reported 3 hours ago - Updated 3 hours ago - 1 reports

Time to Get Tough on India Stealing Our Stuff

Paul Zanetti, Australia Time to Get Tough on India Stealing Our Stuff By Phil Kerpen Quite simply, from pharmaceuticals to motion pictures to software, India is stealing our stuff. India ranks dead last among major economies in protection of ... [Published The Moderate Voice - 3 hours ago]
First reported 10 hours ago - Updated 10 hours ago - 1 reports

A mecca for overpriced medicine

After decades of explosive growth, the cost of health care has climbed at a snail’s pace over the past three years. As the White House boasted this week, per-capita medical spending is now rising at just a third the rate the country has seen for the past ... [Published MSNBC - 10 hours ago]
First reported 15 hours ago - Updated 15 hours ago - 1 reports

Foundation: Yolanda hero did not undergo clinical trial

MANILA -- A foundation clarified that its partnership with giant firm Novartis was never meant as a clinical trial for patients with cancer.In an e-mail sent to ABS-CBNnews.com, The Max Foundation head Pat Garcia-Gonzalez said: “For the past 12 years, ... [Published ABS-CBN News - 15 hours ago]
First reported Apr 19 2014 - Updated Apr 19 2014 - 2 reports

Patent rights meet on US concerns

Cabinet Secretary Ajit Seth will on Monday meet officials from various ministries to discuss concerns raised by the US on India’s management of intellectual property rights (IPRs), it is learnt.The meeting comes just ahead of the release of the US Trade ... [Published Business Standard India - Apr 19 2014]
First reported Apr 18 2014 - Updated Apr 19 2014 - 1 reports

India’s Patent Laws Comes Under Western Scrutiny

At end-April 2014, the US Trade Representative (USTR) will release its Special 301 report, an annual review of US trading partners on their intellectual property (IP) protection record. India and the world will watch closely to see if India is designated ... [Published Spy Ghana - Apr 18 2014]
First reported Apr 17 2014 - Updated Apr 17 2014 - 1 reports

Healthcare costs in U.S. far exceed costs in other countries, report says

AdvertisementAn average one-day hospital stay in the United States cost $4,293 last year, six times more than it did in Argentina and nearly 10 times the cost in Spain, an industry group reported Thursday.Medical procedures, tests, scans and prescription ... [Published Los Angeles Times - Apr 17 2014]
First reported Apr 17 2014 - Updated Apr 17 2014 - 1 reports

Novartis to report Q1 earnings

at 0700 CEST We forecast 1Q14 group sales of USD14.10bn (+4% pro forma LC growth YoY; +0.6% as reported); a group core operating margin of 25.5% (down 80bps vs 1Q'13) and basic core EPS of USD1.29 (+3% in LC; company collected consensus not available ... [Published Invezz - Apr 17 2014]
First reported Apr 17 2014 - Updated Apr 17 2014 - 1 reports

Drug firm Novartis to help Leyte firefighter

RESIDENTS of the village of Sagkahan in Tacloban City view the destruction left by Supertyphoon “Yolanda” on their community. FILE PHOTOMANILA, Philippines—The Swiss-based pharmaceutical transnational manufacturer of a leukemia drug has promised to help ... [Published Philippine Daily Inquirer - Apr 17 2014]
First reported Apr 15 2014 - Updated Apr 15 2014 - 2 reports

A Novartis guinea pig’s complaint

AS a first responder during Supertyphoon “Yolanda,” Dario Raagas helped save lives. Now, the leukemia-stricken firefighter is fighting to save his own.But his fight for survival puts him up against pharmaceutical giant Novartis and its Manila subsidiary ... [Published Malaya Business Insight - Apr 15 2014]
First reported Apr 15 2014 - Updated Apr 15 2014 - 1 reports

Mutations in the Bcr-Abl tyrosine kinase associated with resistance to STI-571

The invention described herein relates to novel genes and their encoded proteins, termed Mutants Associated with Resistance to STI-571 (e.g., T315I Bcr-Abl), and to diagnostic and therapeutic methods and compositions useful in the management of various ... [Published Free Patents Online - Apr 15 2014]
First reported Apr 14 2014 - Updated Apr 15 2014 - 2 reports

Novartis Sues Dr Reddy's Labs Over Patent Infringement

Novartis Pharmaceuticals Corporation moved the District Court of Delaware, US against city-based Dr Reddy’s Laboratories Ltd (DRL) for alleged infringement of its patents.According to Novartis, DRL filed an Abbreviated New Drug Application (ANDA) with ... [Published New Indian Express - Apr 15 2014]
First reported Apr 14 2014 - Updated Apr 14 2014 - 1 reports

Russia may tighten criteria for the patentability of drugs

The Russian Federal Anti-Monopoly Service (FAS) is considering tightening the criteria of patentability, in order to reduce the effects of unreasonably granted drug patents in Russia.According to recent statements by the FAS, unjustified granting of patents ... [Published Pharma Letter - Apr 14 2014]

Quotes

"Both compulsory licence for Nexavar and SC's verdict on Glivec were major blows for American companies as these moves impacted not only their Indian market but sales globally. Besides, now they run a risk of other government evaluating similar strategies" a healthcare expert said
"In another aspect, the subject invention concerns a kit for screening substances for antitumor activity comprising cells and a ligand specific for phosphotyrosine-STAT3 protein, wherein the ligand is directly or indirectly associated with a detectable label. Optionally, the kit can further comprise a substrate for carrying out the assay."
"These are very encouraging results," said Dr. Duensing. "The next step will be moving our findings to clinical exploration to see if the results we found in the lab hold up in patients."
Dr. Kinneret Savitsky , Chief Executive Officer of BioLineRx , said, "We are extremely pleased that our promising and versatile therapeutic candidate is ready to commence a Phase 1/2 clinical trial for a third indication, namely CML. Prof. Nagler's decision to pursue BL-8040 for CML in an independent clinical study is a testament to the potential he sees in our molecule for treating hematologic cancers. Each of these indications stands to benefit from the two main characteristics of BL-8040 - its ability to mobilize cells from the bone marrow into the peripheral blood system, and its ability to induce cancer cellcell death directly."

More Content

All (119) | News (110) | Reports (0) | Blogs (9) | Audio/Video (0) | Fact Sheets (0) | Press Releases (0)
sort by: Date | Relevance
Time to Get Tough on India Stealing Our Stuff [Published The Moderate Voice - 3 hours ago]
A mecca for overpriced medicine [Published MSNBC - 10 hours ago]
Foundation: Yolanda hero did not undergo clinic... [Published ABS-CBN News - 15 hours ago]
Patent rights meet on US concerns [Published Business Standard India - Apr 19 2014]
Cabinet Secretary set to meet top officials ove... [Published Business Standard India - Apr 19 2014]
India’s Patent Laws Comes Under Western Scrutiny [Published Spy Ghana - Apr 18 2014]
Medical Groups To Weigh Costs of Drugs in Care [Published Columbus - Apr 18 2014]
Healthcare costs in U.S. far exceed costs in ot... [Published Los Angeles Times - Apr 17 2014]
IFHP Study Examines Variation in Medical Prices... [Published BioPortfolio - Apr 17 2014]
Novartis to report Q1 earnings [Published Invezz - Apr 17 2014]
Drug firm Novartis to help Leyte firefighter [Published Philippine Daily Inquirer - Apr 17 2014]
Patent Issued for Materials and Methods for Tre... [Published HispanicBusiness.com - Apr 16 2014]
Potential Therapy for Rare, Drug-resistant GISTs [Published Chemotherapy Advisor - Apr 16 2014]
A Novartis guinea pig’s complaint [Published Malaya Business Insight - Apr 15 2014]
Mutations in the Bcr-Abl tyrosine kinase associ... [Published Free Patents Online - Apr 15 2014]
Cancer-stricken Yolanda 'hero' wages battle for... [Published ABS-CBN News - Apr 15 2014]
Novartis Sues Dr Reddy's Labs Over Patent Infri... [Published New Indian Express - Apr 15 2014]
DRL in legal tangle for Novartis’ Gleevec drug [Published Financial Chronicle - Apr 14 2014]
Russia may tighten criteria for the patentabili... [Published Pharma Letter - Apr 14 2014]
BioLineRx : Gets Approval for Investigator-Init... [Published 4 Traders - Apr 14 2014]
Update on BioLineRx's BL-8040 - Analyst Blog [Published DailyMe.Com - Apr 12 2014]
Long-Term Benefit With Dasatinib After Imatinib... [Published The ASCO Post - Apr 12 2014]
Update on BioLineRx's BL-8040 - Analyst Blog [Published Zacks.com - Apr 12 2014]
Cancer Research Funding Still Tight—and Getting... [Published The ASCO Post - Apr 11 2014]
Update on BioLineRx's BL-8040 [Published Yahoo! Finance - Apr 11 2014]
‘Yolanda’ hero Dario Raagas fights for his life... [Published Philippine Daily Inquirer - Apr 11 2014]
Why are Indian generics under attack? One view ... [Published Express Pharma - Apr 11 2014]
Former Port man winning fight against cancer [Published Newbury Port News - Apr 11 2014]
BioLineRx to initiate Phase 1/2 clinical trial ... [Published News-Medical.Net - Apr 10 2014]
Raising the standard of proteomics data [Published Outsourcing Pharma - Apr 09 2014]
1 2 3 4
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Time to Get Tough on India Stealing Our Stuff [Published The Moderate Voice - 3 hours ago]
Paul Zanetti, Australia Time to Get Tough on India Stealing Our Stuff By Phil Kerpen Quite simply, from pharmaceuticals to motion pictures to software, India is stealing our stuff. India ranks dead last among major economies in protection of ...
Turnabout is Fair Play - Why University of Illi... [Published Health Care Renewal - Mar 25 2014]
Since 2006, we have posted repeatedly about  what was then a new species of severe conflicts of interest.  This occurred when leaders of academic medical institutions or other health care non-profit organizations or non-governmental organizations (NGOs) ...
Precision attack on cancer [Published MIT News feed - Mar 12 2014]
Most cancer patients receive one or more of the frontline chemotherapy drugs that have been discovered over the past 50 years. These drugs are often effective but have major drawbacks, including severe side effects and the possibility that tumors will ...
Research and Markets: Investigation Report on C... [Published Business Wire Health News - Mar 11 2014]
DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/2dlz6n/investigation) has announced the addition of the "Investigation Report on China Imatinib Market, 2009-2018" report to their offering. Imatinib is originally ...
“Right to try” laws and Dallas Buyers’ Club: Gr... [Published Science-Based Medicine - Mar 08 2014]
One of my favorite shows right now is True Detective , an HBO show in which two cops pursue a serial killer over the course of over 16 years. Starring Woody Harrelson and Matthew McConaughey, it’s an amazingly creepy show, and McConaughey is amazing ...
1 2
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.